Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| IMNN | IMUNON INC | $10.92M | 2,192,353 | 19.70% | 80.30% | Net Buying | Net Buying | ||
| FBLG | FIBROBIOLOGICS INC | $22.29M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| ACXP | ACURX PHARMACEUTICALS INC | $6.50M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| FEMY | FEMASYS INC | $9.53M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $36.18M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| CLSD | CLEARSIDE BIOMEDICAL INC | $19.68M | 5,234,024 | 25.51% | 74.49% | Net Buying | |||
| PSTV | PLUS THERAPEUTICS INC | $41.69M | 99,264,526 | 0.38% | 23.66% | Net Buying | Net Buying | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $69.94M | 17,661,698 | 29.13% | 25.91% | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $164.73M | 301,709,485 | 16.98% | 10.66% | Net Selling | Net Selling | ||
| CBUS | CIBUS INC | $77.02M | 54,238,382 | 21.28% | 78.72% | Net Buying | |||
| ATYR | ATYR PHARMA INC | $88.29M | 89,004,436 | 74.54% | 17.28% | Net Buying | |||
| GOVX | GEOVAX LABS INC | $16.43M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $18.16M | 68,003,613 | 21.00% | 15.70% | ||||
| FGEN | FIBROGEN INC | $45.74M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Buying | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $29.63M | 57,542,105 | 11.22% | 38.43% | Net Selling | |||
| MBRX | MOLECULIN BIOTECH INC | $12.21M | 30,286,168 | 1.43% | 20.90% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $4.55M | 2,515,305 | 0.71% | 99.29% | ||||
| NRXP | NRX PHARMACEUTICALS INC | $58.52M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| XFOR | X4 PHARMACEUTICALS INC | $18.35M | 5,788,686 | 26.19% | 73.81% | Net Selling | |||
| CING | CINGULATE INC | $19.16M | 5,412,523 | 3.75% | 96.25% | ||||
| LSTA | LISATA THERAPEUTICS INC | $20.03M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| IMUX | IMMUNIC INC | $80.97M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.79M | 51,806,497 | 16.36% | 46.67% | Net Buying | |||
| CRIS | CURIS INC | $21.25M | 12,498,853 | 6.98% | 93.02% | ||||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.93M | 23,858,301 | 10.74% | 60.23% | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.04M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| JSPR | JASPER THERAPEUTICS INC | $40.63M | 16,253,332 | 20.02% | 79.98% | Net Buying | |||
| MYO | MYOMO INC | $32.89M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| OSTX | OS THERAPIES INC | $67.61M | 31,891,933 | 1.89% | 20.70% | Net Selling | |||
| IPSC | CENTURY THERAPEUTICS INC | $41.21M | 86,389,098 | 26.19% | 47.24% | Net Selling | Net Selling | ||
| INTS | INTENSITY THERAPEUTICS INC | $11.67M | 47,057,727 | 4.20% | 4.44% | Net Buying | Net Buying | ||
| ACRV | ACRIVON THERAPEUTICS INC | $51.27M | 31,455,645 | 54.52% | 45.48% | Net Selling | Net Selling | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $43.52M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| SLN | SILENCE THERAPEUTICS PLC | $230.74M | 141,701,848 | 13.95% | 0.09% | ||||
| MTVA | METAVIA INC | $25.17M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| NOTE | FISCALNOTE HOLDINGS INC | $63.00M | 14,349,995 | 30.70% | 69.30% | Net Selling | Net Selling | ||
| MDCX | MEDICUS PHARMA LTD | $49.35M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.51M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| LGVN | LONGEVERON INC | $11.92M | 15,178,575 | 3.85% | 96.15% | Net Selling | Net Selling | ||
| PASG | PASSAGE BIO INC | $22.79M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Selling | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.35M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| CRDL | CARDIOL THERAPEUTICS INC | $92.60M | 82,674,725 | 7.82% | 0.00% | ||||
| EKSO | EKSO BIONICS HOLDINGS INC | $11.54M | 2,611,788 | 0.26% | 99.74% | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $109.67M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| ACET | ADICET BIO INC | $65.75M | 82,709,625 | 62.39% | 19.44% | Net Selling | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $257.38M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| KAPA | KAIROS PHARMA LTD | $25.31M | 20,743,765 | 1.05% | 32.68% | Net Buying | |||
| NKTX | NKARTA INC | $142.05M | 71,024,512 | 62.30% | 37.70% | Net Selling | |||
| ABOS | ACUMEN PHARMACEUTICALS INC | $76.32M | 60,573,425 | 62.08% | 17.23% | Net Selling | |||
| SNTI | SENTI BIOSCIENCES INC | $35.21M | 26,081,139 | 20.78% | 79.22% | Net Buying | |||
| TIL | INSTIL BIO INC | $134.54M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| GUTS | FRACTYL HEALTH INC | $49.74M | 50,289,014 | 48.79% | 51.21% | Net Selling | |||
| CABA | CABALETTA BIO INC | $111.13M | 50,743,101 | 94.52% | 5.48% | ||||
| AUTL | AUTOLUS THERAPEUTICS PLC | $356.63M | 266,141,411 | 62.35% | 0.00% | ||||
| ALGS | ALIGOS THERAPEUTICS INC | $59.48M | 6,151,374 | 6.61% | 93.39% | ||||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $70.35M | 24,425,762 | 54.13% | 45.87% | Net Selling | Net Selling | ||
| RCT | REDCLOUD HOLDINGS PLC | $36.40M | 44,226,635 | 2.40% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.